Portfolio

Axovia Therapeutics

Axovia Therapeutics is developing the first gene therapy to treat diseases caused by cilia dysfunction.

Visit Website
Vantage Biosciences

Vantage Biosciences is an ALSA Ventures company at the forefront of targeting the root cause of vision loss associated with diabetes.

Visit Website
Promatix

Promatix is an ALSA Group company using multi-omic insights to develop the next generation of cancer therapeutics

Visit Website
Montis Biosciences

Develops novel immuno-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumors

Visit Website
Epsilogen

World leader in IgE drugs with a pipeline of therapies to treat solid cancer tumours

Visit Website
Oxford BioTherapeutics

Pipeline of first in class oncology drugs leveraging a proprietary database

Visit Website